Trial protocol for a multicenter randomized controlled trial to assess the efficacy and safety of intravenous ketamine for chronic daily headaches: the “KetHead” trial

BACKGROUND: Chronic daily headaches (CDH) are common and associated with significant morbidity, poor quality of life, and substantial burden on the healthcare system. CDH tends to be refractory to conventional medical management and/or patients cannot afford expensive treatments. It is stipulated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoydonckx, Yasmine, Singh, Mandeep, Gilron, Ian, Khan, James, Narouze, Samer, Dahan, Albert, Curtis, Kathryn, Cao, Xingshan, Kara, Jamal, Bhatia, Anuj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976458/
https://www.ncbi.nlm.nih.gov/pubmed/36855160
http://dx.doi.org/10.1186/s13063-023-07186-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976458/
https://www.ncbi.nlm.nih.gov/pubmed/36855160
http://dx.doi.org/10.1186/s13063-023-07186-3

Ejemplares similares